These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25836932)

  • 1. Nonurothelial bladder cancer and rare variant histologies.
    Willis D; Kamat AM
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):237-52, viii. PubMed ID: 25836932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
    Porten SP; Willis D; Kamat AM
    Curr Opin Urol; 2014 Sep; 24(5):517-23. PubMed ID: 24921905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should histologic variants alter definitive treatment of bladder cancer?
    Willis DL; Porten SP; Kamat AM
    Curr Opin Urol; 2013 Sep; 23(5):435-43. PubMed ID: 23880739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
    Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
    J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What About Variant Histologies in Bladder Cancer?
    Day E; Gavira J; Tapia JC; Anguera G; Maroto P
    Eur Urol Focus; 2024 Mar; 10(2):227-230. PubMed ID: 38849276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
    Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G
    Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer.
    Vlachou E; Johnson BA; Baraban E; Nadal R; Hoffman-Censits J
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438640. PubMed ID: 38870453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
    Philippou P; Kariotis I; Volanis D; Ploumides A; Delakas D
    Urol Int; 2011; 86(3):370-2. PubMed ID: 21325783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.
    Abd El-Latif A; Watts KE; Elson P; Fergany A; Hansel DE
    J Urol; 2013 Apr; 189(4):1263-7. PubMed ID: 23085297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of micropapillary bladder carcinoma].
    Matsumura E; Ashikari A; Tasaki S; Kato S; Ashimine S; Machida N; Toyama H; Oshiro Y; Saito S
    Hinyokika Kiyo; 2012 Jun; 58(6):279-82. PubMed ID: 22874506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
    Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL
    Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
    Shah RB; Montgomery JS; Montie JE; Kunju LP
    Urol Oncol; 2013 Nov; 31(8):1650-5. PubMed ID: 22608543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
    Bansal A; Kumar N; Sharma SC
    J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.